Prepare
Organise user-provided facts and questions for a future consultation.
SPAIN PILOT PROGRAMME
Let’s build a clearer route to genetic support.
Genidi helps adults organise their family history, understand which details may be worth confirming and prepare better questions for a professional conversation. We are now selecting clinics, genetics professionals and laboratories for a controlled first pilot in Spain.
- No exclusivity
- No paid placement
- No guaranteed volume
Genidi does not diagnose, calculate individual risk, select tests or share clinical information with prospective partners at this stage.
BETTER PREPARATION, CLEAR BOUNDARIES
The person arrives with better questions. The professional retains clinical control.
Genidi’s current product provides a five-question educational assessment about family cancer history. It organises only what the person enters, prepares a reviewable summary and, where an approved minimum-information threshold is met, displays educational gene terms that may arise in a professional conversation.
This information is not a diagnosis or test recommendation. During partner recruitment, Genidi collects only provider business, operational and credential information.
Explain
Present sourced educational vocabulary with visible limitations.
Connect, when appropriate
Explore a future route to verified organisations after the pilot controls have been completed.
TWO PARTNERSHIP TRACKS
Two partnership tracks. The same clinical independence.
We begin with one or two clearly defined services. The partner controls assessment, prerequisites and its care route.
TRACK A
Clinics, genetics professionals and counselling providers
For organisations providing clinical genetics, genetic counselling, hereditary-oncology, preventive medicine or professional report-review services.
- A draft public profile, subject to verification and approval.
- Clear scope, delivery mode, languages and service areas.
- A person-facing explanation of what to expect and prepare.
- An enquiry route controlled by the organisation.
The organisation assesses the person, determines clinical indication and explains any test or result. Genidi does not make those decisions.
TRACK B
Laboratories with a clinical gate
For laboratories able to document their authorisation, accreditation, analytical scope and applicable clinical prerequisites.
- A draft catalogue limited to the approved scope.
- Clear clinical and counselling prerequisites.
- Geographic, sample and support information without patient data.
- A laboratory-controlled enquiry and operational route.
Genidi does not select panels, originate orders, receive samples or reports, or interpret results.
AN HONEST JOURNEY
From a family concern to a better-prepared conversation.
Each step separates educational preparation, professional verification and contact. They are not bundled into one permission.
Private preparation
The person answers five questions and reviews an educational summary. Public answers remain temporarily in their browser tab.
Genidi organises without concluding
User-provided facts, limitations, educational terms and consultation questions remain separate.
The person decides
Only after creating an account and accepting the applicable permissions may they request a broad support category.
Genidi verifies before displaying
No organisation appears as an option until its identity, authorisation, credentials, scope and operational route are approved.
Contact remains controlled
Once the pilot is active, the person opens a provider-controlled route; Genidi does not send family history, answers, reports or variants.
Current statusProvider options and contact routes are not yet active. They depend on contracting and verifying the first partner.
PROPOSED PILOT
90 days to validate one journey, with no volume promises.
The period begins only after the applicable verification, agreements and controls are complete.
Validation
Entity, authorisations, owners, privacy, incidents and scope.
Design
Profile, service and a fictional operational case without clinical information.
Controlled activation
Only if all controls pass; a capacity ceiling, never promised volume.
Joint review
Clarity, operational fit, response times and a decision to continue, change or pause.
The pilot will not be evaluated by tests sold or clinical decisions. Genidi does not promise a minimum number of visits, enquiries or contacts.
What an approved partner may receive
- A public profile designed by Genidi and confirmed by the partner before final approval.
- Clear presentation of services, scope, languages, locations and delivery mode.
- Founding Network recognition after approval.
- Direct participation in product development.
- Aggregate measurement of business interactions without clinical content.
Not included in this phase
- Patient referrals or a clinical inbox.
- Exchange of family histories, reports or medical documents.
- Service booking or payment.
- Laboratory API integration.
- Exclusivity, guaranteed volume or paid placement.
ELIGIBILITY
Trust starts before a profile is published.
We are looking for organisations able to legally provide the proposed service in Spain and document their scope.
FAQs- A clearly identified responsible entity and authorised centre.
- Documentable professional credentials or laboratory accreditation.
- Defined service scope, exclusions and prerequisites.
- Named commercial, operational, clinical and privacy owners.
- Complaint, incident and clinical-escalation processes.
- Prices and terms explainable before any future activation.
- An organisation-controlled professional HTTPS route.
- Acceptance that payment cannot influence eligibility or position.
EARLY CONVERSATIONS
Interested in exploring Genidi’s first Spain pilot?
Book a short conversation so we can learn about your organisation, consider one clearly defined initial service and decide whether a next design step is worthwhile.
Do not include patient data, family histories, diagnoses, variants, reports or any other health information.